Enanta Pharmaceuticals, Inc., a biotechnology company, discovers and develops small molecule drugs for virology and immunology indications. The company's product pipeline comprises EDP-514, which is in phase 1b clinical development for the treatment of chronic infection with hepatitis B virus or...
14 insider purchases on record · latest filing 2025-02-12.
Insiders have also filed 272 sale transactions at ENTA.